Magovcevic-Liebisch Ivana

Magovcevic-Liebisch Ivana is listed in filings as Director at Acrivon Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through May 20, 2026, including purchase activity. Recent filings connect the profile to Acrivon Therapeutics, Inc. Common Stock (ACRV), Quanterix Corporation (QTRX), and Vigil Neuroscience, Inc. (VIGL). The current snapshot covers public activity from Oct 3, 2024 to May 20, 2026. Reported amounts are shown as $2.4M to $1.6M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.